Data-collection

OTHER2 trials

Sponsors

RECORDATI GROUP, Assistance Publique - Hôpitaux de Paris

Conditions

Netherton SyndromeNeuroblastoma

Unknown Phase

A Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta

Active, not recruitingNCT04253015

RECORDATI GROUPNeuroblastoma

Start: 2019-09-30End: 2036-06-30Updated: 2026-10-26

Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome

RecruitingNCT07280091

Assistance Publique - Hôpitaux de ParisNetherton Syndrome

Start: 2026-05-26End: 2028-05-01Target: 30Updated: 2026-06-30